Lupin Secures Nod From US FDA for Bromfenac Ophthalmic Solution

Lupine Limited (hereafter Lupin), an international pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to submit a New Drug Application for Bromfenac 0.075% Ophthalmic Solution to be marketed as a vaccine

Metropolis Enhances Diagnostic Center in Ratlam, MP

Metropolis Healthcare, India's leading provider of diagnostic services has opened a state-of-the-art diagnostic center in Ratlam, Madhya Pradesh.

Agilis Robotics Introduces Significant Advancements in Endoluminal Surgery

Agilis Mechanical technology, a main pioneer in careful mechanical technology, is leading a change in perspective in the field of "incisionless" endoluminal medical procedure. The company has made significant technological advancements by...

Pharma Giant Novartis To Acquire MorphoSys For USD 2.9 Billion

Drugmaker Novartis AG said it will procure MorphoSys AG, an engineer of malignant growth therapies, for 2.7 billion euros ($2.9 billion), adding a promising interesting bone-marrow disease treatment possibility to its portfolio. Novartis will...

MedGenome Study: Uncovering Parkinson's Genes in Young Indians

MedGenome, a leading global technology company in South Asia, and the Parkinson's Research Alliance of India (PRAI) conducted a study that identified rare and common variants based on the Polygenic Risk Score (PRS) in Young Onset.

FDA Clears Acepodia's ACE2016 IND Application

Acepodia's, a clinical biotechnology company, is developing best-in-class therapeutics with its unique antibody-cell conjugate (ACC) and allergenic gamma delta 2(d2) T cells to address cancer treatment areas, one of the US. The food.

Merck Animal Health Acquires Elanco's Aqua Business for $1.3B

Merck Animal Health, known outside the United States and Canada as MSD Animal Health, a division of Merck and Co., Inc.,

India's Pharmacy Education Potential: Dr. Ilkay Erdogan Orhan

India has great potential for international relations in pharmaceutical education, says Dr. Ilkay Erdogan Orhan, Dean of the Faculty of Pharmacy at Gazi University, Ankara, Turkey.

Indian Pharma Firms Supply 27 Vaccines to Russian Market

A Russian company approached the Indian embassy in Moscow in search of 27 high-quality vaccines similar to those produced by Western medical authorities.

Sirius Initiates Phase 1 Trial To Treat Thromboembolic Disorders

Sirius Therapeutics, a creative, clinical stage biotech organization, declared it has dosed the main subject in a stage 1, first-in-human clinical preliminary in Australia of SRSD107 on January 30, 2024, its cutting edge siRNA restorative...

© 2024 India Pharma Outlook. All Rights Reserved.